This technology is expected to help save lives by bolstering colon cancer detection rates. Per Medtronic management, GI Genius is the only colonoscope-agnostic AI platform intended to improve polyp detection. The use of AI to improve ADR can improve the quality of colonoscopies, thereby enhancing diagnosis and outcomes for colon cancer patients. The integration of AI into gastroenterology practices could serve as a crucial component in colorectal cancer prevention. The GI Genius module is compatible with any colonoscope video and provides physicians with a powerful tool to fight colorectal cancer. New Module to Aid in Fight Against Colorectal Cancer This demonstrates greater accuracy to help reduce the risk of interval cancer between colonoscopies.

The utilization of the GI Genius module in studies has resulted in a 14% absolute increase in ADR versus colonoscopy alone for both flat (42% increase) and polyploid (36% increase) lesions. The flexibility of this platform allows seamless integration into different clinical workflows, facilitating clinical decision-making and enhancing care quality by reducing variability. The GI Genius module, which acts as a second observer, helps improve the adenoma detection rate (ADR).

The GI Genius module utilizes advanced AI to highlight the presence of suspected precancerous lesions in real-time with a visual marker. It is noteworthy to mention that Medtronic is the exclusive worldwide distributor of the GI Genius module, developed and manufactured by Cosmo Pharmaceuticals. The GI Genius is a computer-aided detection (CADe) system that employs artificial intelligence (AI) to highlight colon regions that may have visual characteristics associated with various forms of mucosal abnormalities. Medtronic plc’s MDT subsidiary Medtronic Canada ULC recently received a Health Canada license for the GI Genius intelligent endoscopy module.

Drive genius 5 licensing